Liver Cirrhosis Market Report 2026

Liver Cirrhosis Market Overview

• Liver Cirrhosis market size has reached to $1.99 billion in 2025 • Expected to grow to $2.88 billion in 2030 at a compound annual growth rate (CAGR) of 7.7% • Growth Driver: Rising Alcohol Consumption Driving Market Growth Due To Increasing Health Risks • Market Trend: Introduction Of Innovative Implantable Device Approved For Advanced Treatment • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Liver Cirrhosis Market?

Liver cirrhosis is a progressive disease in which healthy liver tissue is gradually replaced by scar tissue, impairing the liver’s ability to function properly. This condition results from prolonged liver damage caused by factors such as chronic alcohol consumption, viral hepatitis, or fatty liver disease. The main types of liver cirrhosis are alcoholic cirrhosis, atrophic cirrhosis, biliary cirrhosis, cardiac cirrhosis, and cryptogenic cirrhosis. Alcoholic cirrhosis is a severe liver disease caused by long-term excessive alcohol consumption, leading to liver scarring, dysfunction, and potential liver failure. There are various treatment options available, such as antibiotics, immunosuppressants, and other treatments. The key end users are hospitals, specialty clinics, ambulatory surgical centers, academic and research institutes, and other end users.

What Is The Liver Cirrhosis Market Growth Forecast?

The liver cirrhosis market size is expected to see strong growth in the next few years. It will grow to $2.88 billion in 2030 at a compound annual growth rate (CAGR) of 7.7%. The growth in the forecast period can be attributed to increasing burden of NASH and metabolic syndrome, growing awareness of liver health, expanding access to diagnostic testing, rising demand for advanced liver care, increased healthcare spending on chronic diseases. Major trends in the forecast period include rising prevalence of chronic liver diseases, growing focus on early diagnosis and disease monitoring, increasing demand for long-term disease management, expansion of supportive and symptom-based therapies, rising need for specialized hepatology care.

Global Liver Cirrhosis Market Segmentation

1) By Type: Alcoholic Cirrhosis, Biliary Cirrhosis, Cardiac Cirrhosis, Cryptogenic Cirrhosis 2) By Treatment: Antibiotics, Immunosuppressants, Other Treatments 3) By End Users: Hospitals, Specialty Clinics, Ambulatory Surgical Centers, Academic And Research Institutes, Other End Users Subsegments: 1) By Alcoholic Cirrhosis: Compensated Alcoholic Cirrhosis, Decompensated Alcoholic Cirrhosis, Alcoholic Steatohepatitis (ASH)-Associated Cirrhosis 2) By Biliary Cirrhosis: Primary Biliary Cirrhosis (PBC), Secondary Biliary Cirrhosis, Autoimmune Biliary Cirrhosis 3) By Cardiac Cirrhosis: Right Heart Failure-Induced Cirrhosis, Chronic Passive Congestion Cirrhosis, Ischemic Hepatitis Cirrhosis 4) By Cryptogenic Cirrhosis: Non-Alcoholic Steatohepatitis (NASH)-Associated Cirrhosis, Idiopathic Cirrhosis, Metabolic Syndrome-Associated Cirrhosis

What Is The Driver Of The Liver Cirrhosis Market?

The increase in alcohol consumption is expected to propel the growth of the liver cirrhosis market going forward. Alcohol consumption refers to the intake of alcoholic beverages, typically measured in terms of quantity and frequency. People are increasingly consuming alcohol because it helps them unwind from daily stress, fosters social connections in gatherings, and enhances moments of relaxation, while also being widely promoted through media and becoming more accessible in various settings. Liver cirrhosis treatment for patients with excessive alcohol consumption focuses on managing liver damage through abstinence, medications, and supportive care while addressing alcohol dependence with counseling and rehabilitation. For instance, in December 2024, according to the Bureau of Labor Statistics, a US-based government agency, in 2023, U.S. households spent an average of $294 on alcoholic beverages consumed at home and $343 on those consumed outside the home. Therefore, increasing alcohol consumption drives the liver cirrhosis industry.

Key Players In The Global Liver Cirrhosis Market

Major companies operating in the liver cirrhosis market are F Hoffmann-La Roche Ltd., Abbott Laboratories, Thermo Fisher Scientific Inc., Siemens Healthineers AG, GE HealthCare Technologies Inc., Fujifilm Holdings Corporation, Canon Medical Systems Corporation, Koninklijke Philips N.V., Samsung Medison Co. Ltd., Mindray Medical International Limited, Boston Scientific Corporation, Olympus Corporation, Echosens SA, Hologic Inc., Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Perspectum Diagnostics Ltd., Owlstone Medical Ltd.

Global Liver Cirrhosis Market Trends and Insights

Major companies operating in the liver cirrhosis market are focusing on advancements in treatment options, such as the development of the active implantable medical devices, to improve patient outcomes and expand therapeutic possibilities. Active implantable medical devices are electronically powered implants designed to monitor, support, or improve organ function within the body. For instance, in December 2024, Sequana Medical NV, a Belgium-based medical device company, received the U.S. FDA approval for its alfapump system, the first active implantable medical device in the U.S. for managing recurrent or refractory ascites caused by liver cirrhosis. This breakthrough technology offers a continuous, automated solution for fluid management by transferring excess abdominal fluid to the bladder, significantly reducing dependence on invasive therapeutic paracentesis. Alfapump represents a major advancement in improving patient outcomes and enhancing quality of life with an addressable market of approximately 70,000 patients in the United States.

What Are Latest Mergers And Acquisitions In The Liver Cirrhosis Market?

In September 2023, Galectin Therapeutics, a US-based company that offers treatment for liver cirrhosis collaborated with HistoIndex to showcase findings on liver cirrhosis at the 9th Paris NASH meeting. With this partnership, Galectin Therapeutics and HistoIndex aim to leverage artificial intelligence to enhance the analysis of liver cirrhosis histology, providing deeper insights into disease progression and treatment effectiveness. HistoIndex is a Singapore-based company that offers medical technology.

Regional Outlook

North America was the largest region in the liver cirrhosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Liver Cirrhosis Market?

The liver cirrhosis market consists of revenues earned by entities providing services such as diagnosis and screening services, medical treatment, management services, and patient support. The market value includes the value of related goods sold by the service provider or included within the service offering. The liver cirrhosis market also includes sales of medications, diagnostic tools, medical devices, and therapeutic treatments. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Liver Cirrhosis Market Report 2026?

The liver cirrhosis market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the liver cirrhosis industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.